5-Amino-2-Bromo-3-Methylpyridine | CAS:38186-83-3

We serve 5-Amino-2-Bromo-3-Methylpyridine CAS:38186-83-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Amino-2-Bromo-3-Methylpyridine

Chemical Name:5-Amino-2-Bromo-3-Methylpyridine
CAS.NO:38186-83-3
Synonyms:5-Amino-2-Bromo-3-Methylpyridine
6-bromo-5-methylpyridin-3-amine
5-Amino-2-bromo-3-picoline
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 305.0±37.0 °C at 760 mmHg
Molecular Formula C6H7BrN2
Molecular Weight 187.037
Flash Point 138.2±26.5 °C
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-Amino-2-Bromo-3-Methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Amino-2-bromo-3-picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-2-Bromo-3-Methylpyridine Use and application,6-bromo-5-methylpyridin-3-amine technical grade,usp/ep/jp grade.


Related News: API and raw material are often confused due to the similar usage of the two terms.4-Ethylphenylboronic acid manufacturer API and raw material are often confused due to the similar usage of the two terms.4-(Hydroxymethyl)phenylboronic acid supplier How does the virus spread? The virus is thought to spread from person to person through respiratory droplets emitted by coughing or sneezing — but it’s not clear exactly when a person becomes contagious. There’s currently no evidence that the virus is airborne — meaning, for instance, it doesn’t travel across a large room.3-(4-Chlorobutyl)-1H-indole-5-carbonitrile vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).